| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.66B | +2914.5% |
| Cost of Revenue | $4.78B | +819.4% |
| Gross Profit | -$3.12B | -571.6% |
| R&D Expense | $1.94B | +5.1% |
| SG&A Expense | $1.79B | +44.0% |
| Operating Income | -$6.86B | -62.5% |
| Interest Expense | $103.0M | +255.2% |
| Pre-tax Income | -$6.75B | -43.9% |
| Income Tax | $4.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.57B | -36.2% |
| Accounts Receivable | $102.0M | +292.3% |
| Inventory | $1.35B | +392.0% |
| Current Assets | $13.13B | -29.3% |
| Total Assets | $17.88B | -19.8% |
| Current Liabilities | $2.42B | +84.6% |
| Long-term Debt | $1.23B | +0.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.05B | -92.7% |
| Capital Expenditures | $1.37B | -23.7% |
| Investing Cash Flow | -$1.37B | +23.7% |
| Financing Cash Flow | $99.0M | -99.5% |
| Free Cash Flow | -$6.42B | -45.4% |
| — |
| Net Income | -$6.75B | -44.0% |
| EPS (Basic) | -$7.40 | +67.8% |
| EPS (Diluted) | -$7.40 | +67.8% |
| Total Liabilities |
| $4.08B |
| +46.7% |
| Stockholders' Equity | $13.80B | -29.3% |